ESMO 2024: Natera showcases chemotherapy prediction benefit of cDNA test
The data from the ongoing trial shows that ctDNA positivity can be used to predict overall survival benefit post-surgery in colon cancer patients.
16 September 2024
16 September 2024
The data from the ongoing trial shows that ctDNA positivity can be used to predict overall survival benefit post-surgery in colon cancer patients.
The design of the Lightning Flash 2.0 catheter features MaxID hypotube technology.
The device allows users to stand and move at eye level, enhancing their ability to engage in everyday activities.
The Histolog Scanner’s ultra-fast confocal microscopy enables immediate imaging of resected tissues.
The VORTX system is engineered to oxygenate blood without relying on fibre membranes.
The PROMIS-I study met the primary endpoint finding the company's aerosol delivery system safe and effective in treating non-cystic fibrosis bronchiectasis.
The AI model can accurately predict who is at a high risk of developing sight-threatening diabetic retinopathy up to three years in advance.
Moffitt will assess Cizzle’s biomarker assay for early lung cancer detection with the aim to reduce false positives caused by CT scans.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.